Home / Doxycycline / United States
US ATC A01AB22 · updated 2 Nov 2026
Doxycycline shortage in United States
Is there a Doxycycline shortage in United States?
Yes. As of 2 Nov 2026, 2 Doxycycline products are reported short in United States, the first since 30 Jul 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60) discontinuation | Teva Pharmaceuticals USA, Inc. | 30 Jul 2026 | not given | Not stated |
| US | Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22) discontinuation | Teva Pharmaceuticals USA, Inc. | 30 Jul 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).